BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
A safflower oil based high-fat/high-sucrose diet modulates the gut microbiota and liver phospholipid profiles associated with early glucose intolerance in the absence of tissue inflammation. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 61 Issue 5 Pages: Pub: 2017 May Epub: 2017 Feb 22 Authors Danneskiold-Samsøe NB , Andersen D , Radulescu ID , Normann-Hansen A , Brejnrod A , Kragh M , Madsen T , Nielsen C , Josefsen K , Fretté X , Fjaere E , Madsen L , Hellgren LI , Brix S , Kristiansen K , |
|
|
A safflower oil based high-fat/high-sucrose diet modulates the gut microbiota and liver phospholipid profiles associated with early glucose intolerance in the absence of tissue inflammation. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 61 Issue 5 Pages: Pub: 2017 May Epub: 2017 Feb 22 Authors Danneskiold-Samsøe NB , Andersen D , Radulescu ID , Normann-Hansen A , Brejnrod A , Kragh M , Madsen T , Nielsen C , Josefsen K , Fretté X , Fjaere E , Madsen L , Hellgren LI , Brix S , Kristiansen K , |
|
|
A safflower oil based high-fat/high-sucrose diet modulates the gut microbiota and liver phospholipid profiles associated with early glucose intolerance in the absence of tissue inflammation. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 61 Issue 5 Pages: Pub: 2017 May Epub: 2017 Feb 22 Authors Danneskiold-Samsøe NB , Andersen D , Radulescu ID , Normann-Hansen A , Brejnrod A , Kragh M , Madsen T , Nielsen C , Josefsen K , Fretté X , Fjaere E , Madsen L , Hellgren LI , Brix S , Kristiansen K , |
|
|
A safflower oil based high-fat/high-sucrose diet modulates the gut microbiota and liver phospholipid profiles associated with early glucose intolerance in the absence of tissue inflammation. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 61 Issue 5 Pages: Pub: 2017 May Epub: 2017 Feb 22 Authors Danneskiold-Samsøe NB , Andersen D , Radulescu ID , Normann-Hansen A , Brejnrod A , Kragh M , Madsen T , Nielsen C , Josefsen K , Fretté X , Fjaere E , Madsen L , Hellgren LI , Brix S , Kristiansen K , |
|
|
Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism. ✅
Pharmacological research (Pharmacol Res ) Vol: Issue Pages: Pub: 2018 May 19 Epub: 2018 May 19 Authors Liu J , Yue S , Yan Z , Feng W , Meng X , Wang A , Peng C , Wang C , Yan D , |
|
|
Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism. ✅
Pharmacological research (Pharmacol Res ) Vol: Issue Pages: Pub: 2018 May 19 Epub: 2018 May 19 Authors Liu J , Yue S , Yan Z , Feng W , Meng X , Wang A , Peng C , Wang C , Yan D , |
|
|
Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism. ✅
Pharmacological research (Pharmacol Res ) Vol: Issue Pages: Pub: 2018 May 19 Epub: 2018 May 19 Authors Liu J , Yue S , Yan Z , Feng W , Meng X , Wang A , Peng C , Wang C , Yan D , |
|
|
Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism. ✅
Pharmacological research (Pharmacol Res ) Vol: Issue Pages: Pub: 2018 May 19 Epub: 2018 May 19 Authors Liu J , Yue S , Yan Z , Feng W , Meng X , Wang A , Peng C , Wang C , Yan D , |
|
|
Hydroxysafflor yellow A protects against colitis in mice by suppressing pyroptosis via inhibiting HK1/NLRP3/GSDMD and modulating gut microbiota. ✅
Go to Publication ✅
Toxicology and applied pharmacology (Toxicol Appl Pharmacol ) Vol: 467 Issue Pages: 116494 Pub: 2023 May 15 Epub: 2023 Mar 29 Authors Chen J , Pan M , Wang J , Zhang M , Feng M , Chai X , Zhang Q , Sun Y , |
|
|
Hydroxysafflor yellow A protects against colitis in mice by suppressing pyroptosis via inhibiting HK1/NLRP3/GSDMD and modulating gut microbiota. ✅
Go to Publication ✅
Toxicology and applied pharmacology (Toxicol Appl Pharmacol ) Vol: 467 Issue Pages: 116494 Pub: 2023 May 15 Epub: 2023 Mar 29 Authors Chen J , Pan M , Wang J , Zhang M , Feng M , Chai X , Zhang Q , Sun Y , |
|
|
Safflower polysaccharide ameliorates acute ulcerative colitis by regulating STAT3/NF-?B signaling pathways and repairing intestinal barrier function. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 174 Issue Pages: 116553 Pub: 2024 May Epub: 2024 Apr 8 Authors Qi M , Chu S , Wang W , Fu X , Jiang C , Zhang L , Ali MH , Lu Y , Jia M , Ubul D , Tang H , Li J , Liu M , |
|
|
Safflower polysaccharide ameliorates acute ulcerative colitis by regulating STAT3/NF-?B signaling pathways and repairing intestinal barrier function. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 174 Issue Pages: 116553 Pub: 2024 May Epub: 2024 Apr 8 Authors Qi M , Chu S , Wang W , Fu X , Jiang C , Zhang L , Ali MH , Lu Y , Jia M , Ubul D , Tang H , Li J , Liu M , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
